Clinical trials confirm that a new drug called zolbetuximab can help extend survival in patients with gastric cancer, according to a study published in The New England Journal of Medicine.
All posts in gastric cancer
Clinical trials confirm that a new drug called zolbetuximab can help extend survival in patients with gastric cancer, according to a study published in The New England Journal of Medicine.